Our data were not consistent with the results of a previous meta-analysis30 included four studies with gastric cancer patients, that meta-analysis results demonstrated that the OS of EZH2-negative patients was shorter than that of patients with positive expression of EZH2 (HR = 0.54, 95% CI = 0.05–1.03). Here, EZH2 is linked to gastric cancer.